Navigation Links
Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
Date:6/19/2013

results will be consistent with these forward-looking statements. For more information about the risks and uncertainties that may affect our results, please see the Risk Factors section of our filings with the Securities and Exchange Commission, including our annual report on Form 10-K and quarterly reports on Form 10-Q. We do not intend to update any of the forward-looking statements after the date of this announcement to conform these statements to actual results, to changes in management's expectations or otherwise, except as may be required by law.

Contact:
Ramses Erdtmann
Vice President of Investor Relations and Corporate Communications
Phone: 408-215-3325

U.S. Medical Information, Pharmacyclics:
855-Ibrutinib [(855) 427-8846]


'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
4. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
5. Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
6. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
7. Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid and Sustainable Disease Control Irrespective of Age or High Risk Prognostic Factor
8. Ibrutinib Expanded Access Program Open to Eligible U.S. Patients with Relapsed or Refractory Mantle Cell Lymphoma
9. Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma
10. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
11. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... PharmaPoint: Type 1 Diabetes - Global Drug Forecast ... diabetes (T1D) is an autoimmune disease that permanently destroys beta ... can no longer produce insulin. Over the last 90 years, ... other treatment can be offered to a patient who is ... different times of action - long-acting as well as short ...
(Date:5/27/2015)... NEW YORK , May 27, 2015  Precision ... announced the findings from its 2015 Digital Trends Study ... decision makers are aware of the concepts of big ... fully implement them.  The Health Information ... incentives for healthcare providers to make use of electronic ...
(Date:5/27/2015)... , May 27, 2015  LumiThera Inc., ... non-invasive photobiomodulation (PBM) treatment for ocular disorders and ... Washington State Life Sciences ... 3 recipients of the LSDF matching grants worth ... treatment for subjects with dry age-related macular degeneration ...
Breaking Medicine Technology:PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 2Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 3LumiThera Receives LSDF Commercialization Grant Award 2
... , LAVAL, QC, Aug. 5 /PRNewswire-FirstCall/ - Labopharm Inc. ... it has filed a New Drug Submission (NDS) with ... novel formulation of the antidepressant trazodone. , "We are ... Canada," said James R. Howard-Tripp, President and Chief Executive ...
... WORTH, Texas, Aug. 4 Of the 600,000-800,000 people trafficked across international ... by 2010, human trafficking will be the No. 1 crime worldwide. ... chairman of the department of forensic and investigative Genetics and co-director of ... University of North Texas (UNT) Health Science Center , ...
Cached Medicine Technology:Labopharm files New Drug Submission with Health Canada for novel antidepressant 2Labopharm files New Drug Submission with Health Canada for novel antidepressant 3DNA Helps Reunite Children With Their Families 2DNA Helps Reunite Children With Their Families 3
(Date:5/27/2015)... The BBB Code of Business Practices ... enhance customer trust and confidence in business. The Code ... principles that summarize important elements of creating and maintaining ... business accreditation by BBB. Businesses based in the United ... application procedures will be accredited by BBB. , To ...
(Date:5/27/2015)... Continuing its commitment to finding a cure ... community, SmartPractice® donated $25,000 to HonorHealth Breast ... Vice President of Human Resources Meg Mosher and SmartScrubs ... to Paulla Miller, Sherry Gage, Dr. Linda Greer and ... on April 30. The center is located at 19646 ...
(Date:5/27/2015)... Allred Dental located in San Marcos, CA ... need extensive dental treatment - understand the oral issues they ... their problems. , Dr. Jeff Allred calls it “Dental Case ... assessment of the patient’s oral health and problems together with ... oral health problems. , “The dental case planning process starts ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Black ... customer satisfaction surveys in the multiple services and ... to determine the highest ranked Electronic Health and ... of a special research focus on implemented EHR ... those software vendors with the highest scores in ...
(Date:5/27/2015)... May 27, 2015 The MedSpa at ... FDA-approved dermal filler treatments in Abilene, Texas: Xeomin®, Belotero ... the appearance of glabellar lines, better known as the ... Balance® is designed to treat smoker’s lines around the ... chin, while Radiesse® improves the appearance of smile lines ...
Breaking Medicine News(10 mins):Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2
... , FRIDAY, Aug. 5 (HealthDay News) -- Smoking ... atrial fibrillation, a new study warns. U.S. researchers reviewed ... who were followed for an average of 13 years, and ... time. The risk of the abnormal heart rhythm was ...
... (HealthDay News) -- Children with HIV who receive antiretroviral ... (lipid) levels, and would benefit from guidelines aimed at ... findings are published in JAIDS: Journal of Acquired ... first crucial step in minimizing cardiovascular disease complications and ...
... in Spanish . , ANN ARBOR, Mich. ... be used safely and effectively even in tumors from the ... the University of Michigan Comprehensive Cancer Center. Sentinel lymph ... first node where cancer would likely spread. If that node ...
... --,Smokers who take a multivitamin pill may think they can ... affects of cigarettes, according to a new study. Researchers ... will reduce their risk of cancer, allowing them to light ... a virtuous behavior for a subsequent indulgence, known as the ...
... WHAT: Scientists from around the world will gather ... order to improve health through advances in pharmaceutical sciences ... In recognition of AAPS,s 25th anniversary, this year,s meeting, ... sessions, including more than 60 symposia and roundtables. ...
... , THURSDAY, Aug. 4 (HealthDay News) -- American military veterans ... suicide than fellow students who have never been in the ... poll paints a grave picture of these students, mental health: ... they have considered suicide at some point in their lives, ...
Cached Medicine News:Health News:Children's HIV Drugs May Cause High Cholesterol 2Health News:Sentinel node biopsy safe, effective in head and neck melanomas, U-M study finds 2Health News:Smokers Mistakenly Believe Vitamins Protect Them From Cancer 2Health News:Many Military Vets in College Plagued By Thoughts of Suicide 2Health News:Many Military Vets in College Plagued By Thoughts of Suicide 3
... 6-Place Rotor has a standard 1.5ml rotor and ... adapters. Easy operation (no switches to mess with). ... press the plastic tab to open. Starts and ... and 2000 x g. Only five inches in ...
... which allows user to stop rotor before opening ... stainless steel pin is virtually indestructible. Lid release ... microcentrifuge tubes at low to medium speed (up ... inch x 6 inch footprint. Starts and stops ...
Inquire...
Inquire...
Medicine Products: